Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop
François Mouton‐Liger, Thibault Rosazza, Julia E. Sepúlveda-Díaz, et al.
Glia (2018) Vol. 66, Iss. 8, pp. 1736-1751
Open Access | Times Cited: 133

Showing 26-50 of 133 citing articles:

Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond
Andrew N. Bayne, Jean‐François Trempe
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 23, pp. 4589-4611
Closed Access | Times Cited: 89
The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration
Jared T. Hinkle, Valina L. Dawson, Ted M. Dawson
Movement Disorders (2019) Vol. 34, Iss. 7, pp. 959-969
Open Access | Times Cited: 86
MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury
Jianhang Jiao, Guanjie Zhao, Yang Wang, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 77
NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
Mahbuba Akther, Md. Ezazul Haque, Jooho Park, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8780-8780
Open Access | Times Cited: 69
Pyroptosis, and its Role in Central Nervous System Disease
Yingchao Hu, Bingwei Wang, Sheng Li, et al.
Journal of Molecular Biology (2021) Vol. 434, Iss. 4, pp. 167379-167379
Closed Access | Times Cited: 66
Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
Collin M. Bantle, Warren D. Hirst, Andreas Weihofen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 65
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
Faith L. Anderson, Katharine M. von Herrmann, Angeline S. Andrew, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 63
Nuclear factor‐kappa B (NF‐κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration
Mahsa Dolatshahi, Mohammad Hossein Ranjbar Hameghavandi, Mohammadmahdi Sabahi, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 1, pp. 4101-4123
Closed Access | Times Cited: 59
Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Bora Tastan, Burak I. Ariöz, Şermin Genç
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
Linh Thi Nhat Nguyen, Hữu Đạt Nguyễn, Yun Joong Kim, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 7, pp. 2117-2133
Open Access | Times Cited: 44
Targeting NLRP3 inflammasome for neurodegenerative disorders
Jing Yao, Zhe Wang, Weihong Song, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4512-4527
Closed Access | Times Cited: 34
The systemic immune response in Parkinson’s disease: focus on the peripheral immune component
Johanne Lauritsen, Marina Romero‐Ramos
Trends in Neurosciences (2023) Vol. 46, Iss. 10, pp. 863-878
Open Access | Times Cited: 32
Structural Mechanisms of Mitochondrial Quality Control Mediated by PINK1 and Parkin
Jean‐François Trempe, Kalle Gehring
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168090-168090
Open Access | Times Cited: 31
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
Frida Lind‐Holm Mogensen, Andrea Scafidi, Aurélie Poli, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 29
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 24
PINK1 restrains periodontitis-induced bone loss by preventing osteoclast mitophagy impairment
Ji Sun Jang, Seo Jin Hong, Shenzheng Mo, et al.
Redox Biology (2023) Vol. 69, pp. 103023-103023
Open Access | Times Cited: 24
Regulation of the NLRP3 inflammasome by autophagy and mitophagy
Suman Gupta, Suzanne L. Cassel, Fayyaz S. Sutterwala, et al.
Immunological Reviews (2024)
Closed Access | Times Cited: 9
Insight into interplay between PANoptosis and autophagy: novel therapeutics in ischemic stroke
Heyan Tian, Yun-Xing Lei, Junlin Zhou, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 17
Open Access | Times Cited: 2
CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model
Atsushi Kadowaki, Michael A. Wheeler, Zhaorong Li, et al.
Nature Neuroscience (2025)
Closed Access | Times Cited: 1
Microglial NLRP3 inflammasome activation in multiple sclerosis
Melis Olcum, Bora Tastan, Cagla Kiser, et al.
Advances in protein chemistry and structural biology (2019), pp. 247-308
Closed Access | Times Cited: 69
Neuroglial transmitophagy and Parkinson's disease
Ingrid Moráles, Alberto Sánchez, Ricardo Puertas‐Avendaño, et al.
Glia (2020) Vol. 68, Iss. 11, pp. 2277-2299
Closed Access | Times Cited: 69
AKT Regulates NLRP3 Inflammasome Activation by Phosphorylating NLRP3 Serine 5
Wei Zhao, Chong-Shan Shi, Kathleen A. Harrison, et al.
The Journal of Immunology (2020) Vol. 205, Iss. 8, pp. 2255-2264
Open Access | Times Cited: 62
NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
Yiqun Yan, Yi Fang, Ran Zheng, et al.
Neuroscience (2020) Vol. 446, pp. 323-334
Open Access | Times Cited: 57
Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson’s disease model
Mei-Rong Gao, Min Wang, Yanyan Jia, et al.
Brain Research Bulletin (2020) Vol. 164, pp. 55-64
Closed Access | Times Cited: 51
A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease
Shuxuan Huang, Zhi Chen, Binglin Fan, et al.
Journal of Neuroimmunology (2021) Vol. 354, pp. 577543-577543
Closed Access | Times Cited: 47

Scroll to top